L Arendt-Nielsen Selected Research

Lasers (Laser)

9/2012	Effects of dexmedetomidine on conditioned pain modulation in humans.
9/2010	A novel model of inflammatory pain in human skin involving topical application of sodium lauryl sulfate.
10/2009	Botulinum toxin type A reduces histamine-induced itch and vasomotor responses in human skin.
10/2006	Experimental skin pain and muscle pain induce distinct changes in human trigeminal motoneuronal excitability.
7/2006	Modulation of laser-evoked potentials by experimental cutaneous tonic pain.
1/2005	Segmental inhibition of cutaneous heat sensation and of laser-evoked potentials by experimental muscle pain.
12/2003	Lasers and other thermal stimulators for activation of skin nociceptors in humans.
9/2003	Spatial and temporal profiles of flare and hyperalgesia after intradermal capsaicin.
5/2003	Assessment of nociceptive trigeminal pathways by laser-evoked potentials and laser silent periods in patients with painful temporomandibular disorders.
2/2003	A comparison of hyperalgesia and neurogenic inflammation induced by melittin and capsaicin in humans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L Arendt-Nielsen Research Topics

Disease

65	Pain (Aches) 09/2023 - 01/2000
22	Hyperalgesia 01/2018 - 01/2000
21	Myalgia 01/2017 - 01/2000
10	Osteoarthritis 09/2023 - 01/2014
8	Knee Osteoarthritis 01/2019 - 09/2015
6	Neurogenic Inflammation 07/2017 - 02/2003
5	Referred Pain 01/2005 - 01/2000
4	Inflammation (Inflammations) 01/2014 - 01/2003
3	Neuralgia (Stump Neuralgia) 08/2005 - 04/2001
3	Hypersensitivity (Allergy) 10/2004 - 01/2001
2	Knee Injuries (Knee Injury) 01/2018 - 09/2015
2	Low Back Pain (Lumbago) 01/2018 - 01/2017
2	Postoperative Pain 08/2014 - 09/2004
2	Ganglion Cysts (Ganglion) 01/2014 - 05/2007
2	Facial Pain (Myofacial Pain) 01/2014 - 02/2011
1	Psoriatic Arthritis 09/2023
1	Fibromyalgia (Fibrositis) 09/2023
1	Hypertrophy 01/2019
1	Arthralgia (Joint Pain) 08/2018
1	Paresthesia (Dysesthesia) 01/2017
1	Fatigue 10/2014
1	Cold Hypersensitivity 03/2014
1	Hyperesthesia 09/2012
1	Burns 10/2011
1	Chronic Pain 10/2011
1	Multiple Chemical Sensitivity (Idiopathic Environmental Intolerance) 01/2010
1	Cough 01/2010
1	Eczema 01/2010
1	Asthma (Bronchial Asthma) 01/2010
1	Acute Cholecystitis 10/2004
1	Visceral Pain 10/2004

Drug/Important Bio-Agent (IBA)

26	Capsaicin (Zostrix)FDA Link 01/2018 - 01/2000
8	Analgesics (Analgesic Drugs)IBA 01/2018 - 10/2000
8	Glutamic Acid (Glutamate)FDA Link 01/2014 - 08/2001
7	Biomarkers (Surrogate Marker)IBA 09/2022 - 08/2001
5	Histamine (Histamine Dihydrochloride)FDA Link 09/2017 - 10/2009
4	Lidocaine (Xylocaine)FDA LinkGeneric 01/2018 - 02/2000
4	Opioid Analgesics (Opioids)IBA 10/2011 - 10/2000
4	Ketamine FDA LinkGeneric 09/2004 - 02/2000
3	Nerve Growth Factor (NGF)IBA 01/2017 - 10/2011
3	Bee Venoms (Bee Venom)IBA 12/2009 - 01/2003
3	N-Methylaspartate (NMDA)IBA 05/2007 - 10/2000
3	Dihydrotachysterol (AT 10)IBA 02/2000 - 01/2000
2	Pain-FreeIBA 09/2023 - 09/2012
2	Imipramine (Janimine)FDA LinkGeneric 01/2018 - 05/2001
2	AcidsIBA 01/2018 - 01/2017
2	Clobazam (HR 376)IBA 01/2018 - 01/2017
2	SolutionsIBA 01/2018 - 11/2001
2	gamma-Aminobutyric Acid (GABA)IBA 01/2018 - 01/2017
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2017 - 01/2001
2	Menthol FDA Link 10/2014 - 03/2014
2	Fentanyl (Sublimaze)FDA LinkGeneric 10/2011 - 04/2003
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2007 - 09/2003
2	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 08/2005 - 04/2001
2	antineoplaston A10 (A 10)IBA 08/2004 - 06/2004
2	Alfentanil (Alfenta)FDA LinkGeneric 09/2003 - 07/2001
2	Serotonin (5 Hydroxytryptamine)IBA 04/2001 - 01/2000
1	EpitopesIBA 01/2019
1	Collagen Type XIBA 01/2019
1	aggrecanaseIBA 08/2018
1	Collagen Type III (Type III Collagen)IBA 08/2018
1	EnzymesIBA 01/2018
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2018
1	Oxycodone (Oxycontin)FDA LinkGeneric 01/2018
1	Type A Botulinum Toxins (Botox)FDA Link 07/2017
1	Adenosine Diphosphate (ADP)IBA 07/2017
1	Protons (Proton)IBA 01/2017
1	Acid Sensing Ion ChannelsIBA 01/2017
1	BenzodiazepinesIBA 01/2017
1	Tolterodine Tartrate (Detrol)FDA Link 01/2017
1	Irritants (Vesicants)IBA 10/2014
1	CollagenIBA 01/2014
1	catch-relaxing peptide (Mytilus)IBA 01/2014
1	Matrix Metalloproteinases (MMPs)IBA 01/2014
1	C-Reactive ProteinIBA 01/2014
1	Adrenergic Receptors (Adrenergic Receptor)IBA 09/2012
1	Dexmedetomidine FDA Link 09/2012
1	Buprenorphine (Subutex)FDA LinkGeneric 10/2011
1	Opioid Receptors (Opioid Receptor)IBA 10/2011
1	Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate)IBA 09/2010
1	PerfumeIBA 01/2010
1	Prostaglandins BIBA 12/2009
1	incobotulinumtoxinA FDA Link 10/2009
1	Estrogens (Estrogen)FDA Link 05/2007

Therapy/Procedure

10	Lasers (Laser) 09/2012 - 02/2003
8	Knee Replacement Arthroplasty (Total Knee Replacement) 09/2023 - 08/2014
8	Injections 01/2016 - 01/2000
5	Bite Force (Occlusal Forces) 06/2010 - 01/2000
4	Intradermal Injections 09/2003 - 02/2000
3	Diffuse Noxious Inhibitory Control 09/2012 - 01/2005
2	Activities of Daily Living (ADL) 01/2018 - 09/2015
2	Intramuscular Injections 04/2002 - 11/2001
1	Therapeutics 01/2018
1	Oral Administration 01/2018
1	Endurance Training 10/2014
1	Reoperation 08/2014
1	Replacement Arthroplasty 09/2012
1	Analgesia 12/2009
1	Electrodes (Electrode) 01/2005
1	Aftercare (After-Treatment) 10/2004